MS news notes: Stem cell transplant, Lemtrada, treating seniors

Columnist Ed Tobias comments on the week's top MS news

Ed Tobias avatar

by Ed Tobias |

Share this article:

Share article via email
banner for

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening:

Stem cell transplant found to be safe, effective in recent study

Autologous hematopoietic stem cell transplant (aHSCT) has been approved in Sweden since 2016 for some patients whose MS is active. A recent study discussed in the MS News Today story “Stem cell therapy found safe, effective in RRMS study” reviewed 174 people in that country who were treated with the procedure between 2004 and 2020.

Nearly three-quarters of patients with relapsing-remitting multiple sclerosis (RRMS) showed no signs of disease activity five years after aHSCT treatment, and 65% showed no disease activity after 10 years. About half saw some improvements in their disability.

There were some side effects, including bacterial, viral, and fungal infections. Five people had to be admitted to intensive care, but no deaths were connected to the treatment.

“We believe that aHSCT could benefit a greater number of MS patients and should be included as a standard of care for highly active MS,” the researchers concluded.

I agree with them, and I bet many of you do, too.

Recommended Reading
banner image for Ed Tobias' column

A topical reminder to prepare for a disaster while living with MS

Lemtrada holds the line on MS activity

Before I began treatment with Lemtrada (alemtuzumab) several years ago, my neurologist described it to me as “stem cell lite.” The medication depleted my B-cells and T-cells with the hope that they would repopulate as normal immune cells, rather than the type associated with my MS.

The story “Lemtrada controlled RRMS disease activity more than a decade” reports on the results of a lengthy, open-label follow-up of patients being treated with this disease-modifying therapy (DMT).

The study says that over 11 years, Lemtrada’s “therapeutic effects on [relapse rates], disability, and MRI outcomes, including annual brain volume loss, were maintained and most participants either did not require additional courses or needed just one additional course.” The researchers concluded that the benefits-versus-risk balance for Lemtrada is positive for people with RRMS who failed to respond well to other treatments or who hadn’t previously been treated.

I had no dramatic improvement after I began Lemtrada treatments, and my MS progressed slowly. In my case, it was always hard to be sure how well one of my DMTs was working, but I felt a little better on Lemtrada, for a while. The benefits for me, I believe, outweighed the risks.

What treatments are best for older people with MS?

If you’ve read my column before, you’ll likely know that I’m an MS senior; at 75 years old, I’ve been living with this illness for 43 years. So I was delighted to read the story “Neurologists share treatment preferences for older adults with MS.”

A two-stage survey of 224 neurologists in the first round, and 180 in the second, reported that nearly two-thirds of them usually recommend a high-efficacy therapy as the initial treatment for older adults newly diagnosed with MS. The most common reasons cited for selecting a high-efficacy treatment were high disease activity and progressive disease.

“Most neurologists agreed that people diagnosed with MS earlier in life and with stable disease while on a treatment should continue with that treatment as they age past the late 50s. About a third of the neurologists said they would consider stopping treatment for patients older than age 55 who haven’t had any signs of disease activity for the previous five years,” the story notes.

Many of the neurologists who responded to these surveys were located in Europe. I suspect that if the survey had been limited to doctors in the U.S., the treatment attitude would have been less aggressive. This old guy, who was treated with a high-efficacy DMT while in my late 60s, thinks there should be no arbitrary age barrier to aggressive treatment. I also believe there should be more research into treating people who are 50 and older.

Do you agree? Please share your thoughts in the comments below.


Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews, and are intended to spark discussion about issues pertaining to multiple sclerosis.

Comments

Joseph Brian Moore avatar

Joseph Brian Moore

I agree that there should be no difference between a young person and an older person getting treatment. Lack of treatment is just another way of saying "You're old and you don't don't have much value in the rest of your life."

Reply
Sarah Shapiro avatar

Sarah Shapiro

Not necessarily. Are we talking RRMS or non-active Progressive disease? Ocrevus is only slightly effective in non-active progressive disease, especially PPMS and it is the only option for PPMS. This may not be worth the side effects in an older person. An aging immune system is prone to more UTIs and URI's. maybe it's not ageism, but a risk benefits decision.

Reply
Cori Mcdermott avatar

Cori Mcdermott

Lemtrada worked GREAT for me!!

Reply
Joan Dalessandro avatar

Joan Dalessandro

Us old MSers are ignored or neurologists so threatened by fear of secondary infections that they will not pursue more aggressive treatments, ie, Lemtrada. And then we are not eligible for inclusion in drug studies. There are as yet no really effective therapies that stop new lesions as well as stopping progression. And MS IS the same disease whether it's RRMS, SPMS or PMS. About the only therapy I am willing to try at this point is an antiretroviral. I believe in the EBV as causation. But I would have to get HIV to get that treatment.

Reply
Beth DeMartino avatar

Beth DeMartino

Thank you for your informative article. Like you, I had the Lemtrada treatment in my late 60's. I have been diagnosed with MS for 30 years. I had no improvement in my disability. However, I choose to think that the treatment slowed down the worsening of my disability!! Keep moving no matter what!!

Reply
Ed Tobias avatar

Ed Tobias

Sounds like we're traveling similar roads, Beth. You're right...gotta keep on movin'.

Ed

Reply
Jackie Hajji avatar

Jackie Hajji

I agree with you 100% Ed. Life does not cease nor become less valuable at 60. I was diagnosed at 37 and just turned 60. I had aHSCT at 52. I am so glad I was offered the treatment on a compassionate basis, and great results lasted roughly 4-5 years in remission. I do think I am much better now, though, than if I had had to just settle for steady progression of my MS.

I now take Mayzent, which I compared to a contact at Novartis as "HSCT Lite" or a topping up, if you will, of my stem cell treatment. I think older adults would be extremely likely to volunteer for trials. We need that data, and as a society, we need to stop devaluing older adults in general!

Reply
Ed Tobias avatar

Ed Tobias

Hi Jackie,

Thanks for sharing that info. Yes, we need better data about the affects of DMTs on we older folks. I wish I knew how to make it happen.

Ed

Reply
Paul Nielsen avatar

Paul Nielsen

My neuro has allowed me to stop Avonex at 70. I'm only two weeks in so I'm just a little aprehensive.

Reply
Ed Tobias avatar

Ed Tobias

Hi Paul,

Avonex, as you probably know, is an ancient MS treatment...designed to stop relapses but not to slow progression. I was in its Phase 3 trial around 1995 and I got needle fatigue, big-time, after about 7 years of jabbing myself. It's not the most effective medication in the MS world. Why did you decide to stop? Have you talked with your neuro about starting another DMT if your MS progresses after you stop Avonex?

Ed

Reply
Jane Coultis avatar

Jane Coultis

I am 62, diagnosed in 1981 (age:20) & have been receiving Ocrevus treatment for about 5 years. I agree there should be no arbitrary age barrier to aggressive treatment. And, I agree that there should be more research into treating people who are 50 and older.

Reply
Ronnie Perry avatar

Ronnie Perry

I am 65 years old & was diagnosed with PPMS 4 years ago. My neurologist put me on Ocrevus. I had lost total use of my right arm & hand along with partial use of my right leg. Over a short period of time, 2 to 3 months partial use of both limbs came back. I am still getting the infusions of ocrevus

Reply
Ed Tobias avatar

Ed Tobias

Hi Ronnie,

I'm glad that you were able to regain some of use of your limbs after receiving treatment. You're good evidence that someone shouldn't be kept from receiving a medication only because of their age.

Ed

Reply
Brian avatar

Brian

Yes I agree, there should be more studies on people with ms 50 and older!!!

Reply
JOHN NOWE avatar

JOHN NOWE

At 69 years old, my neurologist and I are entertaining stopping treatment. My latest MRI showed no change and the last three MRIs also have no apparent change. I was diagnosed at 24 with PPMS, with most of my issues being in the areas of muscle spasms, nerve issues, and fatigue. I have also had cognitive issues and short-term memory loss which have progressed to the point that I was forced to retire early at 62 on disability.
I am fortunate that I do not experience episodes that debilitate me or have me in a wheelchair. I have walking troubles, especially with drop foot so I trip. I use a number of mobility aids depending on how I feel on any given day.
I'm not sure if I should stop DMTs and wonder if continuing use would be detrimental.

Reply
Ed Tobias avatar

Ed Tobias

Hi John,

I'm not a medical professional so I really can't answer your question. But, it's important, and good, that you and your neuro are having a discussion about this, rather than the neuro demanding that you stop or you deciding to stop on your own. I started Lemtrada around age 65 and am glad that I did. I'm also glad that a decided, going into the treatment, that I would only do two rounds and that it would be my final DMT.

Ed

Reply
Pamela avatar

Pamela

I am 72. We all experience MS differently and react to meds differently. I am on a high-efficacy DMT. I agree keep medicating as strong as tolerated. If a Doctor/insurance company took me off and I got worse, I don't want to hear, "Oops!"

Reply
Ed Tobias avatar

Ed Tobias

Pamela - That's a great way to put it. "Oops" is not a word I ever want to hear from a doctor.

Ed

Reply
Joan Quilter avatar

Joan Quilter

Regarding the stem cell treatment for MS, the patient must be in pretty good shape and able to walk a certain distance. Years ago, I wanted my daughter to have the treatment, but she didn't qualify. Also, it's not as foolproof as made out to be. Some patients die when their immune system is suppressed or destroyed.

Reply
Ed Tobias avatar

Ed Tobias

Hi Joan,

Yes, someone considering being treated with a stem cell transplant needs to do a lot of research before deciding to go that route. It's not foolproof (no treatment) and some patients die. That also happens with other treatments. aHSCT seems to work best when its used early after an MS diagnosis and it doesn't seem to always be effective for more than a few years. But, I think it should be more available as a treatment choice than it is.

Ed

Reply
Susan Addison avatar

Susan Addison

I too am a senior, age 72 years young. I have SPMS, am unable to walk, deal with cognitive issues, have a weak voice, hearing loss, and neurogenic bowel and bladder concerns. I have multiple additional comorbidities. My diagnosing neurologist whom I had seen for the past 15 years, recently partially closed his practice. I had been driving 3 hours round trip to see him, and had every confidence in him. There is no neurologist specializing in MS where I live. Needless to say, I was distraught. Over the years, and after having been on Beta Seron, Tysabri, Gilenya, and Aubagio, my neurologist put me on Ocrevus. I had the worst ever relapse initially. After a while, my progression more or less leveled off. When I was forced to seek a new neurologist, she immediately took me off Ocrevus due to my age. I was afraid, but agreed to try going without a DMT as a trial. One slight advantage, if you can call it that, was that I receive monthly IVIG (Gamma globulin) infusions due to my primary immune deficiency, CVID. This was used in the past to treat MS, before the more modern DMTs were developed. So perhaps that gives me an edge. While it was scary to stop DMT, it ultimately has worked out well for me. I try to follow research on this subject, and do agree that the decision should not reflect an arbitrary age cut off, but rather the decision should be in the hands of the individual neurologist and the patient guided by ongoing research.

Reply
Ed Tobias avatar

Ed Tobias

Hi Susan,

Thanks for sharing all of this. It sounds as if you and your neurologist had that benefit/risk decision before all of your treatment choices were made and that's great. I'm very glad that the decisions all seem to have been the right ones and I'm glad all has worked out well. Here's to more Senior Power in the MS world.

Ed

Reply
Livia Sousa avatar

Livia Sousa

I’ m neurologist treating ms patients even bafore interferon was available
I used all approved and off label drugs
I never decided by myself stop DMD because of age Even so I sow worsening disease when ‘stable’ old patients decid by themself stop treatment
So I completly agree with you

Reply
Ed Tobias avatar

Ed Tobias

Hi Livia,

I like neurologists who use everything possible to work with their patients to treat MS. It's unfortunate that some patients decide to discontinue their treatments on their own, if those treatments have been effective. However, I understand that there may be many factors involved in their decisions. But neurologists should not decide remove a treatment, or refuse to prescribe one, based solely on age, as long as the patient wants to continue it.

Ed

Reply
Joan Due-Gundersen avatar

Joan Due-Gundersen

Am 72 years old. Was diagnosed with Primary Progressive MS in 2007 ( 16 years ago). Have had no treatment for it. Wonder if you know of anything I can do?

Reply
Ed Tobias avatar

Ed Tobias

Hi Joan,

I don't know where you are located but it seems strange to me that you were not offered any treatment when you were diagnosed. There are only a few treatments that are being used for PPMS but it is certainly worthwhile to ask your neurologist about them.

Ed

Reply
Sam D'Uva avatar

Sam D'Uva

I agree with your thoughts and recommendation

Reply
Liv Skartveit avatar

Liv Skartveit

Dear Ed
I rally agree about the treatment offered old people!
I have eagerly discussed to get treatment since the first interferon came in 1993, and I went to Finland and bought it.
Later I got some interferon and later Copaxone in my local hospital here in Norway.
In 2016, nearly 70 years old, I had a consultation in Tisch center in New York. They recommended Rituximab, which my local neurologist insisted there was no indication for at my age! I had to find two other local hospitals and travel quite far to get infusions each 6 months. Then the pandemic came and we stopped medication.
Now I feel progression, I am 76 - and I have started asking/fighting again.
I will fight for my tax-financed medical treatment! If impossible, somewhere there is money-interested institutions which
will sell it...
Best wishes
- Liv

Reply
Ed Tobias avatar

Ed Tobias

Hi Liv,

I'm not familiar with the treatment protocols are in Norway but I do know that the Tisch Center is highly regarded. Rituxamab isn't approved to treat MS in the US but it is approved to treat certain cancers. But, it's often prescribed "off label" for MS here and is similar to Ocrevus. You're a year older than I am and I ended my MS treatments after I completed two rounds of Lemtrada. I felt at my age I'd received as much benefit from a DMT as I would ever get. But, if you feel progression and that you would benefit from resuming treatment with a DMT I would certainly encourage you to fight that fight.

Ed

Reply
Kathy Allen avatar

Kathy Allen

Hi. I am 70 years old. I have had MS for 50 years. Initially, I was on prednisone on & off. About 2000, I was referred to 'the', the 'only' MS Clinic in the city, it now has 3000 patients. Early on, I was on interferon then Avonex but my antibodies were high) & it was discontinued. I've had one infusion & was trialed with fampridine but because my walking speed didn't improve, I was discontinued despite my walking distance greatly improving.
Short story, I haven't been offered anything despite asking. I think that younger people are being treated. I live in Manitoba.When I see the neurologist, I feel that my symptoms are being recorded & that's it.
It was interesting to hear stories from older persons with MS. Good luck!
Kathy
Just recently, other things, comorbidities, have begun osteoporisis, hypoglycemia (?)

Reply
Ed Tobias avatar

Ed Tobias

Hi Kathy,

I'm sorry you've had those problems. I don't know what the treatment protocols are like in the various provincial health systems in Canada but I find it strange that you were removed from treatments that were working for you. Keep in mind, however, that fampridine and prednisone are only treating symptoms...they don't do anything to slow disease progression. On the other hand, your infusion (although you don't say what it was) may have been a disease-modifying therapy. Have you asked your neuro the reason for discontinuing it and the fampridine?

Ed

Reply
Kristin avatar

Kristin

Stopping DMT's because of no apparent disease progression confuses me – like closing your umbrella in a rainstorm because you're not getting wet or stopping insulin in a diabetic. No disease progression and activity is kind of the point, isn't it?

Reply
Ed Tobias avatar

Ed Tobias

Kristin,

Yep!

Ed

Reply
Tina Blunk avatar

Tina Blunk

Exactly!

Reply
Allison Morgan avatar

Allison Morgan

I was finally diagnosed with SPMS in 2012 at the age of 55, after having experienced symptoms for at least 15 years (leg weakness, foot drop, loss of dexterity and strength of left hand, falling, vision problems). I just missed the chance to join the Phase 3 trial of Ocrevus. A year later, I became a subject in the Phase 3 double-blind trial of Siponimod, now called Mayzent. One pill a day for 5 years, what could be easier than that? Plus lots of quarterly testing for the EDSS. I still continued to progress but slowly. Does anyone remember the peg test, moving pegs into the holes and taking them out again? Well, my left hand tried at the beginning of the trial and by halfway through the 5 years, it just refused to pick up those darn little white pegs. I started using a forearm crutch, moved to a house with few stairs, retired, and moved my horse to a barn less than a mile from home. At the end of the trial, I found out that I had been receiving the trial drug, Siponimod, and they were extending the trial for two more years. By the end of all this, the participants were told that if their disease was “active “ according to the latest MRI, they could continue on Mayzent courtesy of the drug company. But they didn’t consider my disease to be “active”, meaning no new or enhancing lesions in my brain. Still, my new neurologist (previous doctor retired at 67), found private funding to allow me to continue with the Mayzent. At my 6-month follow-up, she recommended that I discontinue the Mayzent, based on my blood pressure and my age. At my next birthday, I would be 65. The drug had not been tested on ‘elderly’ patients so there was no safety data.

So I have been MS drug free since 2021. My MS has really progressed. Of course, the pandemic has had something to do with that. I’m this [ ] far from needing a wheelchair. Even worse, I may have to give up riding my horse. But I’m not going to give up! I’m going to get off my butt and get moving. Right after a cup of tea…😄 🇨🇦💁🏇

Reply
Ed Tobias avatar

Ed Tobias

Hi Allison,

Thanks for sharing all of that. It seems as if your neurologist is on the ball, so I'm surprised that she didn't suggest another treatment when you had a problem tolerating the Mayzent. In the U.S. there are more than 20 DMTs approved to treat MS and I suspect the number is around that in Canada. I guess he problem may be getting approval your provincial health plan, just as we have trouble getting approval from private insurance or Medicare.

I've found that physical therapy and exercise can help slow my symptoms, although I've used a scooter to get around for many years. One of the best things for my body and my mind was horseback riding. When I was in my mid-60s I worked with a hippotherapist and got back on a horse for the first time since I was a kid. It was great for my balance and leg strength. So, find a way to keep getting up on that horse...even if you need to find someone to help you do it.

Ed

Reply
Yolande Sander avatar

Yolande Sander

I was diagnosed at age 53 (symptoms started at 50). For the last 10 years, my Spinal MRI has shown increased progression and I am now declared disabled looking at probable wheelchair usage. After being on Avonex since diagnosis, I have just had my first Ocrevus dose and hope that this will prevent wheelchair dependency. I am still a full-time teacher and feel that treatment should be maximised until I decide to stop.

Reply
Ed Tobias avatar

Ed Tobias

Hi Yolande,

I totally agree with you. After having a risk/benefit discussion with your neurologist you, as the patient, should be the one who makes the final treatment decision. I hope that your Ocrevus treatments will slow your progression and wish you luck.

Ed

Reply
Heather Ryan avatar

Heather Ryan

I totally agree that "older" ms patients should be treated for our disease. I have been on Ocrevus for 5 years and I am much better now that I am 63 than when I started taking it. Some small percentage of ms-ers on Ocrevus improve, though I have been unable to find a number in my searches. When I started on Ocrevus, I had not been able to walk much more than a quarter mile before my gait got sloppy and I needed to sit very still for 45 minutes before inflammation went down so that I could walk reasonably well again. I am now able to walk 2 miles before I need to sit. (I also use a neural sleeve to allow me to go this distance.). I am hoping for more improvement.

Reply
Ed Tobias avatar

Ed Tobias

Hi Heather,

Thanks for writing and I'm glad that Ocrevus has helped you so much. From what I can judge, it seems to provide more help to people with relatively mild MS, which is how I would classify someone who can still walk half a quarter mild. It's super that you can now do two and I hope you'll be able to do ever better.

How do you like the neural sleeve? How is it's comfort and, if you've used something like a Bioness, how does it compare?

Ed

Reply
Victoria Gatt avatar

Victoria Gatt

could you please inform me where stem cells treatment is done?

Reply
Ed Tobias avatar

Ed Tobias

Hi Victoria -

Stem cell transplants, which are different from stem cell treatments, are not approved in the U.S. as an MS treatment. Some are done, experimentally. They are also available in some other countries, such as Mexico.

Here's more info: https://multiplesclerosisnewstoday.com/stem-cell-therapy-and-ms/

Ed

Reply

Leave a comment

Fill in the required fields to post. Your email address will not be published.